A comparison of five schizophrenia drugs finds most newer treatments fare no better than an older generic drug, despite higher costs, according to a study released Monday.
The only exception is Eli Lilly and Co.'s Zyprexa, which may be better than the other medicines. Apart from being the most expensive drug, the study found Zyprexa users experienced dramatic weight gain and developed a higher risk of diabetes
